{"id":3451,"date":"2016-07-07T08:31:58","date_gmt":"2016-07-07T12:31:58","guid":{"rendered":"https:\/\/medicarereport.org\/?p=3451"},"modified":"2016-07-07T08:31:58","modified_gmt":"2016-07-07T12:31:58","slug":"study-brand-name-drugs-high-copays-soak-medicare-part-d-patients","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=3451","title":{"rendered":"Study: Brand-Name Drugs\u2019 High Copays Soak Medicare Part D Patients"},"content":{"rendered":"<p>(By Rachel Bluth for Kaiser Health News)<\/p>\n<p>A new study takes a fresh measure of generic drugs\u2019 price advantages, revealing how much more Medicare Part D patients shelled out in copayments for two popular brand-name drugs in 2013.<\/p>\n<p>The result: 10.5 times more.<\/p>\n<p>Copayments averaged $42 for both Crestor, a cholesterol medication, and Nexium, taken for acid reflux, according to researchers whose study was published Wednesday <a href=\"http:\/\/content.healthaffairs.org\/content\/35\/7\/1237.abstract\" target=\"_blank\">in Health Affairs.<\/a><\/p>\n<p>The consumers\u2019 cost for generic therapeutic equivalents was $4, they said.\u00a0 <a href=\"http:\/\/khn.org\/news\/study-brand-name-drugs-high-copays-soak-medicare-part-d-patients\/?utm_campaign=KHN%3A+First+Edition&amp;utm_source=hs_email&amp;utm_medium=email&amp;utm_content=31390044&amp;_hsenc=p2ANqtz--ulb04svahMzAIO-VF6knAsRyy4NvPsGnLBmFuT_DlVTb8ay5KiZT-LLhCMfRJlv0vvqefHC8PskuhPZmWhinI9TDKew&amp;_hsmi=31390044\" target=\"_blank\">Read article here&#8230;&#8230;<\/a><\/p>\n<p style=\"font: 15px\/1.6 'Open Sans', serif; margin: 0px 0px 15px; padding: 0px; outline: 0px; border: 0px currentColor; color: #444444; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; vertical-align: baseline; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: inherit; background-color: #ffffff; -webkit-text-stroke-width: 0px;\">Kaiser Health News\u00a0is\u00a0a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n<p style=\"font: 15px\/1.6 'Open Sans', serif; margin: 0px 0px 15px; padding: 0px; outline: 0px; border: 0px currentColor; color: #444444; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; vertical-align: baseline; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: inherit; background-color: #ffffff; -webkit-text-stroke-width: 0px;\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-899 \" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png\" alt=\"khn-logo1\" width=\"92\" height=\"48\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-1024x533.png 1024w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-390x205.png 390w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png 1600w\" sizes=\"auto, (max-width: 92px) 100vw, 92px\" \/><\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Rachel Bluth for Kaiser Health News) A new study takes a fresh measure of generic drugs\u2019 price advantages, revealing<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,15],"tags":[],"class_list":["post-3451","post","type-post","status-publish","format-standard","hentry","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3451"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3451\/revisions"}],"predecessor-version":[{"id":3452,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3451\/revisions\/3452"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}